Group V phospholipase A2 increases pulmonary endothelial permeability through direct hydrolysis of the cell membrane

Pulmonary Circulation

Volumn 2, Issue 2, 2012, Pages 182-192

  Muñoz, Nilda M ^a   Desai, Anjali ^b   Meliton, Lucille N ^c   Meliton, Angelo Y ^c   Zhou, Tingting ^b   Leff, Alan R ^c   Dudek, Steven M ^b  

^a ST LUKE S MEDICAL CENTER   (Philippines)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Actin; Acute lung injury; Barrier function; Cytoskeleton; Phospholipase A2; Vascular permeability

Indexed keywords

EID: 84969994875     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.4103/2045-8932.97604     Document Type: Article

References (47)

1. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009;37:1574-9.
2. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-93.
3. Bosma KJ, Taneja R, Lewis JF. Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: Current and experimental approaches. Drugs 2010;70:1255-82.
4. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: A clinical review. Lancet 2007;369:1553-64.
5. Maniatis NA, Kotanidou A, Catravas JD, Orfanos SE. Endothelial pathomechanisms in acute lung injury. Vascul Pharmacol 2008;49:119-33.
6. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001;91:1487-500.
7. Boyanovsky BB, Webb NR. Biology of secretory phospholipase A2. Cardiovasc Drugs Ther 2009;23:61-72.
8. Lambeau G, Gelb MH. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 2008;77:495-520.
9. Edelson JD, Vadas P, Villar J, Mullen JB, Pruzanski W. Acute lung injury induced by phospholipase A2. Structural and functional changes. Am Rev Respir Dis 1991;143(5 Pt 1):1102-9.
10. Kim DK, Fukuda T, Thompson BT, Cockrill B, Hales C, Bonventre JV. Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome. Am J Physiol 1995;269(1 Pt 1):L109-18.
11. Nakos G, Kitsiouli E, Hatzidaki E, Koulouras V, Touqui L, Lekka ME. Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005;33:772-9.
12. Muñoz NM, Meliton AY, Meliton LN, Dudek SM, Leff AR. Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. Am J Physiol Lung Cell Mol Physiol 2009;296: L879-87.
13. Sato R, Yamaga S, Watanabe K, Hishiyama S, Kawabata K, Kobayashi T, et al. Inhibition of secretory phospholipase A2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model. Exp Lung Res 2010;36:191-200.
14. Dudek SM, Munoz NM, Desai A, Osan CM, Meliton AY, Leff AR. Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. Am J Respir Cell Mol Biol 2011;44:361-8.
15. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004;279:24692-700.
16. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001;108:689-701.
17. Zhu X, Learoyd J, Butt S, Zhu L, Usatyuk PV, Natarajan V, et al. Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel. Am J Respir Cell Mol Biol 2007;36:585-93.
18. Troyanovsky B, Alvarez DF, King JA, Schaphorst KL. Thrombin enhances the barrier function of rat microvascular endothelium in a PAR-1-dependent manner. Am J Physiol Lung Cell Mol Physiol 2008;294:L266-75.
19. Wu S, Cioffi EA, Alvarez D, Sayner SL, Chen H, Cioffi DL, et al. Essential role of a Ca2+-selective, store-operated current (ISOC) in endothelial cell permeability: determinants of the vascular leak site. Circ Res 2005;96:856-63.
20. Pruzanski W, Lambeau G, Lazdunski M, Cho W, Kopilov J, Kuksis A. Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2. Biochim Biophys Acta 2007;1771:5-19.
21. Lo CM, Keese CR, Giaever I. Impedance analysis of MDCK cells measured by electric cell-substrate impedance sensing. Biophys J 1995;69:2800-7.
22. Lo CM, Keese CR, Giaever I. Cell-substrate contact: another factor may influence transepithelial electrical resistance of cell layers cultured on permeable filters. Exp Cell Res 1999;250:576-80.
23. Vestweber D, Winderlich M, Cagna G, Nottebaum AF. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 2009;19:8-15.
24. Kikawada E, Bonventre JV, Arm JP. Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2alpha activation. Blood 2007;110:561-7.
25. Kim YJ, Kim KP, Han SK, Munoz NM, Zhu X, Sano H, et al. Group V phospholipase A2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A2. J Biol Chem 2002;277:36479-88.
26. Han SK, Kim KP, Koduri R, Bittova L, Munoz NM, Leff AR, et al. Roles of Trp31 in high membrane binding and proinflammatory activity of human group V phospholipase A2. J Biol Chem 1999;274:11881-8.
27. Kim KP, Rafter JD, Bittova L, Han SK, Snitko Y, Munoz NM, et al. Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation. J Biol Chem 2001;276:11126-34.
28. Munoz NM, Kim YJ, Meliton AY, Kim KP, Han SK, Boetticher E, et al. Human group V phospholipase A2 induces group IVA phospholipase A2-independent cysteinyl leukotriene synthesis in human eosinophils. J Biol Chem 2003;278:38813-20.
29. Munoz NM, Meliton AY, Lambertino A, Boetticher E, Learoyd J, Sultan F, et al. Transcellular secretion of group V phospholipase A2 from epithelium induces beta 2-integrin-mediated adhesion and synthesis of leukotriene C4 in eosinophils. J Immunol 2006;177:574-82.
30. Dull RO, Dinavahi R, Schwartz L, Humphries DE, Berry D, Sasisekharan R, et al. Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: A new role for the glycocalyx. Am J Physiol Lung Cell Mol Physiol 2003;285:L986-95.
31. Ohtsuki M, Taketomi Y, Arata S, Masuda S, Ishikawa Y, Ishii T, et al. Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. J Biol Chem 2006;281:36420-33.
32. Kawabata K, Fujioka D, Kobayashi T, Saito Y, Obata JE, Nakamura T, et al. Inhibition of secretory phospholipase A2 activity attenuates acute cardiogenic pulmonary edema induced by isoproterenol infusion in mice after myocardial infarction. J Cardiovasc Pharmacol 2010;56:369-78.
33. Kitsiouli E, Nakos G, Lekka ME. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta 2009;1792:941-53.
34. Balestrieri B, Arm JP. Group V sPLA2: Classical and novel functions. Biochim Biophys Acta 2006;1761:1280-8.
35. Wijewickrama GT, Kim JH, Kim YJ, Abraham A, Oh Y, Ananthanarayanan B, et al. Systematic evaluation of transcellular activities of secretory phospholipases A2. High activity of group V phospholipases A2 to induce eicosanoid biosynthesis in neighboring inflammatory cells. J Biol Chem 2006;281:10935-44.
36. Zeiher BG, Steingrub J, Laterre PF, Dmitrienko A, Fukiishi Y, Abraham E. LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit Care Med 2005;33:1741-8.
37. Huang F, Subbaiah PV, Holian O, Zhang J, Johnson A, Gertzberg N, et al. Lysophosphatidylcholine increases endothelial permeability: Role of PKCalpha and RhoA cross talk. Am J Physiol Lung Cell Mol Physiol 2005;289:L176-85.
38. Yan S, Chai H, Wang H, Yang H, Nan B, Yao Q, et al. Effects of lysophosphatidylcholine on monolayer cell permeability of human coronary artery endothelial cells. Surgery 2005;138:464-73.
39. Dial EJ, Tran DM, Romero JJ, Zayat M, Lichtenberger LM. A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury. Shock 2010;33:634-8.
40. Butler BD, Davies I, Drake RE. Effect of lysophosphatidylcholine on the filtration coefficient in intact dog lungs. Am J Physiol 1989;257(5 Pt 2): H1466-70.
41. Sun C, Wu MH, Guo M, Day ML, Lee ES, Yuan SY. ADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signalling. Cardiovasc Res 2010;87:348-55.
42. Birukova AA, Birukov KG, Gorshkov B, Liu F, Garcia JG, Verin AD. MAP kinases in lung endothelial permeability induced by microtubule disassembly. Am J Physiol Lung Cell Mol Physiol 2005;289:L75-84.
43. Niknami M, Patel M, Witting PK, Dong Q. Molecules in focus: Cytosolic phospholipase A2-alpha. Int J Biochem Cell Biol 2009;41:994-7.
44. Nagase T, Uozumi N, Aoki-Nagase T, Terawaki K, Ishii S, Tomita T, et al. A potent inhibitor of cytosolic phospholipase A2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2003;284:L720-6.
45. Nagase T, Uozumi N, Ishii S, Kume K, Izumi T, Ouchi Y, et al. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol 2000;1:42-6.
46. Singleton PA, Chatchavalvanich S, Fu P, Xing J, Birukova AA, Fortune JA, et al. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res 2009;104:978-86.
47. Singleton PA, Dudek SM, Ma SF, Garcia JG. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem 2006;281:34381-93.